Medtronic announced restructuring plans to cut annual costs by $450 million - $475 million by fiscal 2023 as the medical device maker introduces a new operating model to simplify its ...

Medtronic is undertaking a restructuring that will cut costs by $450 million to $475 million annually and include an unspecified number of job cuts. The medical device giant — based in Ireland ...

(Reuters) -Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and ...

The Food and Drug Administration identified the recall of Medtronic's MiniMed 600 Series Insulin Pumps as a "Class I" recall. This is the most serious type of recall and means that use of such ...

May 25 (Reuters) - Medtronic Plc (MDT.N), opens new tab on Thursday forecast annual profit below Wall Street estimates, as a strong U.S. dollar and persistently high costs of raw goods weighed on ...

Medtronic expects the separation of its diabetes business to be immediately profitable and improve margins, as diabetes devices require unique commercial and manufacturing strategies. The company ...